Definition of Resectable Stage III Non-small Cell Lung Cancer (NSCLC): A Clinical Case Review by a Pan-European Expert Panel

被引：0

作者：

Brandao, M. ^{[1
]}

Prisciandaro, E. ^{[2
]}

Xenophontos, E. ^{[3
]}

Mariolo, A. ^{[4
]}

Sadeghi, A. H. ^{[5
]}

Filippi, A. R. ^{[6
]}

Levy, A. ^{[7
]}

Bandura, A. ^{[8
]}

Caramella, C. ^{[9
]}

Dickhoff, C. ^{[10
]}

de Margerie-Mellon, C. ^{[11
]}

Faivre-Finn, C. ^{[12
]}

Portik, D. ^{[3
]}

Sanchez-Lorente, D. ^{[13
]}

De Ruysscher, D. ^{[14
]}

Smit, E. ^{[15
]}

Gobbini, E. ^{[16
]}

Fadel, E. ^{[17
]}

Ruffini, E. ^{[18
]}

Olmetto, E. ^{[19
]}

Cortiula, F. ^{[20
]}

Bahce, I. ^{[10
]}

Houda, I.

Opitz, I. ^{[21
]}

Naidoo, J. ^{[22
]}

Edwards, J. ^{[23
]}

Remon, J. ^{[7
]}

Benitez, J. C. ^{[24
]}

Trujillo, J. C. ^{[25
]}

Derks, J. ^{[26
]}

Amrane, K. ^{[27
]}

Hartemink, K. ^{[28
]}

Stathopoulos, K. ^{[1
]}

Hendriks, L.

Iglesias, M. ^{[29
]}

Occhipinti, M. ^{[30
]}

Guckenberger, M. ^{[21
]}

Levra, N. Giaj ^{[31
]}

Girard, N. ^{[16
]}

Reguart, N.

Mercier, O.

Bironzo, P. ^{[32
]}

Hofman, P. ^{[33
]}

Petersen, R. Horsleben ^{[34
]}

De Angelis, R.

Abgral, R. ^{[35
]}

Terrisse, S. ^{[36
]}

Popat, S. ^{[37
]}

Pierret, T. ^{[38
]}

Blum, T. Gerriet ^{[39
]}

机构：

[1] Univ Bruxelles, Inst Jules Bordet Hop, Brussels, Belgium

[2] UZ Leuven Campus Gasthuisberg, Leuven, Belgium

[3] EORTC, Brussels, Belgium

[4] Inst Thorax Curie Montsouris, Inst Mutualiste Montsouris IMM, Paris, France

[5] Erasmus Univ, Med Ctr, Rotterdam, Netherlands

[6] Fdn IRCCS Policlin San Matteo Univ Pavi, Pavia, Italy

[7] Gustave Roussy, Paris, France

[8] Med Univ Gdansk, Gdansk, Poland

[9] Hop Marie Lannelongue, Grp Hosp Paris St Joseph, Paris, France

[10] Amsterdam UMC, Canc Ctr Amsterdam, Amsterdam, Netherlands

[11] Hop St Louis, AP HP, Paris, France

[12] Christie NHS Fdn Trust, Manchester, Lancs, England

[13] Hosp Clin Barcelona, Barcelona, Spain

[14] Maastro Clin Maastricht Radiat Oncol, Maastricht, Netherlands

[15] Leiden Univ, Med Ctr, Leiden, Netherlands

[16] Inst Curie, Paris, France

[17] Univ Paris Sud, Hop Marie Lannelongue, Paris, France

[18] Univ Torino, Osped Molinette, Turin, Italy

[19] Azienda Osped Univ Careggi, Florence, Italy

[20] Azienda Osped Univ Santa Maria Misericordia Udine, Udine, Italy

[21] Univ Hosp Zurich, Zurich, Switzerland

[22] Beaumont Hosp, Dublin, Ireland

[23] Sheffield Teaching Hosp NHS Fdn Trust, Sheffield, S Yorkshire, England

[24] Hosp Univ Reg Virgen Victoria, Malaga & Biomed Res Inst Malaga IBIMA, Malaga, Spain

[25] Hosp Santa Creu & Sant Pau, Barcelona, Spain

[26] Maastricht Univ, Med Ctr, Maastricht, Netherlands

[27] Ctr Hosp Pays Morlaix, Morlaix, France

[28] Antoni leeuwenhoek Hosp, Netherlands Canc Inst, Amsterdam, Netherlands

[29] Hosp Parc Tauli Sabadell, Barcelona, Spain

[30] IRCCS Fdn Ist Nazl Tumori, Milan, Italy

[31] IRCCS Osped Sacro Cuore Don Calabria, Verona, Italy

[32] Univ Torino Osped S Luigi Gonzaga, Turin, Italy

[33] CHU Nice, Hop Pasteur, Nice, France

[34] Copenhagen Univ Hosp, Rigshospitalet, Copenhagen, Denmark

[35] Univ Bretagne Occidentale, Brest, France

[36] Univ Paris Cite, Hop St Louis, AP HP Nord, Paris, France

[37] Royal Marsden Hosp Chelsea, London, England

[38] CHU Lyon, Hop Louis Pradel, Lyon, France

[39] HELIOS Klin, Berlin, Germany

[40] Univ Torino, Osped San Giovanni Battista, Turin, Italy

[41] Azienda Osped Univ Integrata Verona, Osped Borgo Trento, Verona, Italy

来源：

JOURNAL OF THORACIC ONCOLOGY | 2023年 / 18卷 / 11期

关键词：

Resectable; Stage III; Non-small cell lung cancer;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P1.28-09

引用

页码：S292 / S293

页数：2

共 50 条

[21] Combined preoperative radiochemotherapy for non-small cell lung cancer (NSCLC) stage III UICC
Rube, C
Thomas, M
Riesenbeck, D
Lipp, R
Semik, M
Willich, N
EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1065 - 1065
[22] Temporal trends in clinical and pathologic stage discordance in resectable non-small cell lung cancer
Santos, Giordano Fabricio Cittolin
Knapp, Brendan
Flanagan, Mary Ellen
Tohmasi, Steven
Kozower, Benjamin D.
Meyers, Bryan F.
Govindan, Ramaswamy
Puri, Varun
Morgensztern, Daniel
Brandt, Whitney S.
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
[23] Phase III study of neo-adjuvant chemotherapy in resectable non-small cell lung cancer (NSCLC)
Depierre, A
Milleron, B
Moro, D
Quoix, E
Lebeau, B
Chastang, C
Braun, D
Janicot, H
Paillot, N
Gouva, S
Coudert, B
Breton, JL
Lemarie, E
Lebas, FX
Coetmeur, D
Thiberville, L
Brehot, JM
EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1053 - 1053
[24] Staging of non-small cell lung cancer (NSCLC): A review
Tsim, S.
O'Dowd, C. A.
Milroy, R.
Davidson, S.
RESPIRATORY MEDICINE, 2010, 104 (12) : 1767 - 1774
[25] The role of neoadjuvant chemotherapy in marginally resectable or unresectable stage III non-small cell lung cancer
Spásová, I
Petera, J
Hytych, V
NEOPLASMA, 2002, 49 (03) : 189 - 196
[26] Sociodemographic factors impacting clinical trial enrollment and outcomes in stage III non-small cell lung cancer (NSCLC).
Feliciano, Josephine Louella
Woldemichael, Andinet
Mullins, C. Daniel
JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
[27] Paclitaxel, gemcitabin, and cisplatin in non-resectable non-small cell lung cancer (NSCLC)
Sorensen, JB
Stenbygaard, LE
Hansen, HH
Osterlind, K
EUROPEAN JOURNAL OF CANCER, 1999, 35 : S258 - S258
[28] Use of postoperative radiotherapy (PORT) for resectable non-small cell lung cancer (NSCLC)
Bekelman, JE
Rosenzweig, KE
Bach, PB
Schrag, D
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S117 - S118
[29] Chemoradiation for stage III non-small cell lung cancer
Ramella, Sara
Fiore, Michele
Iurato, Aurelia
Trodella, Luca E.
Trodella, Lucio
D'Angelillo, Rolando M.
EUROPEAN JOURNAL OF ONCOLOGY, 2013, 18 (01): : 5 - 13
[30] Management of stage III non-small cell lung cancer
Tabchi, Samer
Kassouf, Elie
El Rassy, Elie
Kourie, Hampig Raphael
Martin, Jocelyne
Campeau, Marie-Pierre
Tehfe, Mustapha
Blais, Normand
SEMINARS IN ONCOLOGY, 2017, 44 (03) : 163 - 177

← 1 2 3 4 5 →